Kobayashi Pharmaceutical Co Ltd is a renowned company that upholds strong values and an influential corporate philosophy. With a commitment to excellence, Kobayashi Pharmaceutical emphasizes innovation, research, and development to provide top-quality healthcare solutions. The company's core values revolve around customer satisfaction, integrity, and social responsibility. By consistently delivering trusted products, Kobayashi Pharmaceutical aims to improve the overall wellness and quality of life for individuals worldwide. With its dedicated team and progressive approach, Kobayashi Pharmaceutical Co Ltd continually strives to be a market leader in the pharmaceutical industry.

Kobayashi Pharmaceutical Co Ltd is primarily present in Japan. The company is a renowned pharmaceutical corporation based in Japan, known for its diverse range of healthcare and personal care products. With its headquarters in Tokyo, Kobayashi Pharmaceutical has established a strong presence and reputation in the domestic market. As a leader in the industry, the company continuously strives to provide innovative and high-quality solutions to improve the health and well-being of its consumers in Japan and beyond.

Kobayashi Pharmaceutical Co Ltd has achieved several significant milestones throughout its history. One notable achievement is the development of innovative healthcare products that cater to various consumer needs. The company has successfully introduced a wide range of over-the-counter drugs, personal care products, and medical devices to the market. Additionally, Kobayashi Pharmaceutical Co Ltd has expanded its global presence, establishing partnerships and subsidiaries in different countries. Its commitment to quality and research has earned the company a strong reputation in the industry. Overall, Kobayashi Pharmaceutical Co Ltd continues to make noteworthy progress in delivering trusted and reliable products to improve the well-being of its customers.

Kobayashi Pharmaceutical Co Ltd is a renowned Japanese company that specializes in healthcare and personal care products. With a rich history dating back to its establishment in 1887, Kobayashi Pharmaceutical Co Ltd has become a trusted name in the industry. Over the years, the company has expanded its product portfolio and diversified into various sectors, including pharmaceuticals, cosmetics, and medical devices. With a commitment to innovation and quality, Kobayashi Pharmaceutical Co Ltd has successfully catered to the evolving needs of consumers. Today, it stands as a leading player in the global market, offering a wide range of high-quality products that enhance the health and well-being of individuals worldwide.

The main competitors of Kobayashi Pharmaceutical Co Ltd in the market include companies like Lion Corporation, Santen Pharmaceutical Co Ltd, and Takeda Pharmaceutical Company Limited. These competitors operate in various segments, such as personal care, eye care, and pharmaceuticals. Kobayashi Pharmaceutical Co Ltd faces tough competition from these companies in terms of market share, product offerings, and customer base. However, Kobayashi Pharmaceutical Co Ltd's strong brand reputation, innovative product portfolio, and commitment to quality help maintain its position as a key player in the industry.

Kobayashi Pharmaceutical Co Ltd is primarily active in the healthcare industry.

The business model of Kobayashi Pharmaceutical Co Ltd is centered around the development, production, and sale of pharmaceutical and healthcare products. It focuses on providing innovative and high-quality solutions for various health issues. Kobayashi Pharmaceutical Co Ltd delivers a broad range of products, including over-the-counter drugs, dietary supplements, toiletries, and medical devices. With a commitment to research and development, the company strives to improve people's well-being globally. Kobayashi Pharmaceutical Co Ltd combines its expertise in both traditional and modern medicine to address the diverse needs of its customers. This company remains dedicated to promoting health and enhancing the quality of life through its comprehensive product portfolio.

Kobayashi Pharmaceutical Co의 P/E 비율은 24.77입니다.

Kobayashi Pharmaceutical Co의 P/S 비율은 2.41입니다.

Kobayashi Pharmaceutical Co에 대한 AlleAktien 품질 점수는 3/10입니다.

예상되는 Kobayashi Pharmaceutical Co 매출은 178.29 조. JPY입니다.

예상되는 Kobayashi Pharmaceutical Co 이익은 17.34 조. JPY입니다.

Kobayashi Pharmaceutical Co Ltd is a Japanese company that specializes in the manufacturing and distribution of health and beauty products. It has developed and brought to market a wide range of medical and cosmetic products since its founding in 1919, known for their high effectiveness and quality. The company's main division is pharmaceutical manufacturing, producing a variety of medicines for various diseases. The product range includes not only prescription medications, but also over-the-counter (OTC) products such as anti-inflammatory drugs, painkillers, and cough medicines. Kobayashi is also a major provider of eye drops and antibiotics and holds a leading position in the Japanese market for gastrointestinal drugs. Another important business sector for Kobayashi is the production of health and wellness products. The company offers a wide range of products, from multivitamin supplements and dietary supplements to weight loss products and anti-aging creams and skincare products. Kobayashi is particularly known for its high-quality patch products, which provide quick pain relief and healing for injuries. Kobayashi is also involved in the manufacturing of insect repellents and repellents. The company holds a leading position in the Japanese market for mosquito repellents and sprays and also offers products to protect against other insects such as fleas and ticks. In addition, Kobayashi has established a subsidiary, Kobayashi Create, which focuses on the development of performance and sports protective equipment. The company produces products such as knee pads and wrist guards, as well as compression clothing to help athletes prevent injuries and improve their performance. Kobayashi's business model is based on developing products that provide added value to customers. The company sees itself as a pioneer in the field of health and beauty products and therefore places great importance on research and development to offer its customers the best products on the market. Advanced market analysis helps the company better understand the needs and requirements of customers and develop more targeted products as a result. Kobayashi's global presence is steadily growing. The company operates in Europe, Asia, and North America, working closely with local partners to distribute its products worldwide and serve a wide range of customers. Kobayashi's strong market position and wide product range make it a key player in the global health market. In summary, Kobayashi Pharmaceutical Co Ltd is a successful company specializing in the development and manufacturing of high-quality health and beauty products. The company is committed to providing added value to its customers and places great importance on research, development, and market analysis to constantly develop new products and expand its range. With its global presence and strong market position, Kobayashi is an important player in the global health market.

Kobayashi Pharmaceutical Co은(는) 연간 번의 배당을 통해 90 JPY의 배당금을 지급합니다.

Kobayashi Pharmaceutical Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Kobayashi Pharmaceutical Co의 ISIN은 JP3301100008입니다.

Kobayashi Pharmaceutical Co의 WKN은 920477입니다.

Kobayashi Pharmaceutical Co의 티커는 4967.T입니다.

지난 12개월 동안 Kobayashi Pharmaceutical Co은(는) 101 JPY 의 배당금을 지급했습니다. 이는 약 1.78 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Kobayashi Pharmaceutical Co은(는) 107.77 JPY의 배당금을 지급할 것으로 예상됩니다.

Kobayashi Pharmaceutical Co의 현재 배당 수익률은 1.78 %입니다.

Kobayashi Pharmaceutical Co은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Kobayashi Pharmaceutical Co은(는) 지난 23년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 107.77 JPY의 배당금이 예상됩니다. 이는 배당수익률 1.9 %에 해당합니다.

Kobayashi Pharmaceutical Co은 '비사이클 소비' 섹터에 속합니다.

Kobayashi Pharmaceutical Co의 마지막 배당금을 59 JPY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Kobayashi Pharmaceutical Co는 90 JPY를 배당금으로 지급했습니다.

Kobayashi Pharmaceutical Co의 배당금은 JPY에 지급됩니다.